Cargando…

Analyzing epidermal growth factor receptor mutation status changes in advanced non‐small‐cell lung cancer at different sampling time‐points of blood within one day

BACKGROUND: We investigated whether different sampling time‐points within one day would influence epidermal growth factor receptor mutation (EGFRm) status in plasma and evaluated the clinical outcomes according to the quantity analysis of EGFRm in circulating tumor DNA (ctDNA) in non‐small‐cell lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jin, Bai, Hua, Hong, Chaoyu, Wang, Jie, Mei, Tong‐hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494457/ https://www.ncbi.nlm.nih.gov/pubmed/28437026 http://dx.doi.org/10.1111/1759-7714.12443

Ejemplares similares

One-day point prevalence of emerging bacterial pathogens in a nationwide sample of 62 German hospitals in 2012 and comparison with the results of the one-day point prevalence of 2010
por: Wegner, Christian, et al.
Publicado: (2013)

Tumor immune microenvironment in epidermal growth factor receptor-mutated non-small cell lung cancer before and after epidermal growth factor receptor tyrosine kinase inhibitor treatment: a narrative review
por: Liu, Lihui, et al.
Publicado: (2021)

Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung
por: Duan, Jianchun, et al.
Publicado: (2015)

One Small Step for a Yeast - Microevolution within Macrophages Renders Candida glabrata Hypervirulent Due to a Single Point Mutation
por: Brunke, Sascha, et al.
Publicado: (2014)

Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned
por: Lee, Dae Ho, et al.
Publicado: (2015)

Forecasting large aftershocks within one day after the main shock
por: Omi, Takahiro, et al.
Publicado: (2013)

Analyzing the Sample Geometry Effect on Mechanical Performance of Drilled GFRP Connections
por: Zhu, Yongcheng, et al.
Publicado: (2022)

Clinical outcome of epidermal growth factor receptor‐tyrosine kinase inhibitors therapy for patients with overlapping kirsten rat sarcoma 2 viral oncogene homolog and epidermal growth factor receptor gene mutations
por: Zhang, Hong, et al.
Publicado: (2015)

Epidermal Growth Factor Receptor Mutation Status and the Impact on Clinical Outcomes in Patients with Non-Small Cell Lung Cancer
por: Huang, HM, et al.
Publicado: (2023)

Bronchial Washing Fluid Versus Plasma and Bronchoscopy Biopsy Samples for Detecting Epidermal Growth Factor Receptor Mutation Status in Lung Cancer
por: Zhang, Xinyu, et al.
Publicado: (2021)

Diagnostic Value of Mutation-Specific Antibodies for Immunohistochemical Detection of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
por: Chen, Zi, et al.
Publicado: (2014)

Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer
por: Bhatt, Vijaya Raj, et al.
Publicado: (2016)

Epidermal Growth Factor Receptor Mutation Status: Does Younger Mean More Frequently Mutated?
por: Wójcik, P, et al.
Publicado: (2017)

Rad51 in regulating the radiosensitivity of non‐small cell lung cancer with different epidermal growth factor receptor mutation status
por: Zhong, Xing, et al.
Publicado: (2015)

Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation
por: Ko, How-Wen, et al.
Publicado: (2022)

The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma
por: Zhao, Wei, et al.
Publicado: (2020)

Important Points in Toxic Epidermal Necrolysis Management
por: Al-Shaqsi, Sultan
Publicado: (2019)

Multiple Sampling in One Day to Optimize Smear Microscopy in Children with Tuberculosis in Yemen
por: Al-Aghbari, Nasher, et al.
Publicado: (2009)

Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma
por: Zhou, Xiuzhi, et al.
Publicado: (2018)

Dissecting and analyzing the Subclonal Mutations Associated with Poor Prognosis in Diffuse Glioma
por: Bai, Ming, et al.
Publicado: (2022)

Cytomorphological features as predictors of epidermal growth factor receptor mutation status in lung adenocarcinoma
por: Sharma, Saniya, et al.
Publicado: (2018)

Synchronous mucinous and non-mucinous lung adenocarcinomas with different epidermal growth mutational status
por: Linhas, Rita, et al.
Publicado: (2017)

Evolution of cis- and trans-regulatory divergence in the chicken genome between two contrasting breeds analyzed using three tissue types at one-day-old
por: Wang, Qiong, et al.
Publicado: (2019)

Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?
por: Kim, Seung Tae, et al.
Publicado: (2015)

Day-to-day and within-day biological variation of cell-free DNA
por: Madsen, Anne Tranberg, et al.
Publicado: (2019)

The 28 + 28 day design is an effective sampling time for analyzing mutant frequencies in rapidly proliferating tissues of MutaMouse animals
por: Marchetti, Francesco, et al.
Publicado: (2021)

Cost-effectiveness analysis of different sequences of osimertinib administration for epidermal growth factor receptor-mutated non-small-cell lung cancer
por: Li, Wenqian, et al.
Publicado: (2021)

Relationship between epidermal growth factor receptor gene mutation and copy number in Chinese patients with non-small cell lung cancer
por: Zhang, Lan-Jun, et al.
Publicado: (2012)

TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib
por: Yu, Ruofei, et al.
Publicado: (2021)

Analyzing Effects of Naturally Occurring Missense Mutations
por: Zhang, Zhe, et al.
Publicado: (2012)

The Status of the EGFR T790M Mutation is associated with the Clinical Benefits of Osimertinib Treatment in Non-small Cell Lung Cancer Patients: A Meta-Analysis
por: Zhao, Zhe, et al.
Publicado: (2020)

Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status
por: Hsu, Chia-Hung, et al.
Publicado: (2016)

One Day on Earth
Publicado: (2011)

One Day Later
por: Van Allen, Eliezer M.
Publicado: (2010)

One day more
por: Kim, Tae-Il
Publicado: (2012)

Comparison of the point-of-care blood gas analyzer versus the laboratory auto-analyzer for the measurement of electrolytes
por: Jain, Anunaya, et al.
Publicado: (2009)

Tumor genomics and response to chemotherapy in advanced non-small cell lung cancer with exon 20 insertion epidermal growth factor receptor mutations
por: Wang, Yue, et al.
Publicado: (2020)

Applications of radiomics-based analysis pipeline for predicting epidermal growth factor receptor mutation status
por: Liu, Zefeng, et al.
Publicado: (2023)

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
por: Cibulskis, Kristian, et al.
Publicado: (2013)

A Review of the Correlation Between Epidermal Growth Factor Receptor Mutation Status and (18)F-FDG Metabolic Activity in Non-Small Cell Lung Cancer
por: Jiang, Maoqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_avd1epu0n3rhf5im8j0sk6g6d8